Effects of the cocaine- and amphetamine-regulated transcript peptide on the turnover of central dopaminergic neurons.
The effects of the cocaine- and amphetamine-regulated transcript (CART) peptide on central dopaminergic (DA) neurons were examined in ovariectomized, estrogen-primed Sprague-Dawley rats in both the morning and afternoon. Intracerebroventricular administration of 1 microg, but not lower doses of the CART peptide (55-102), either in the morning or afternoon produced a prolonged increase in the 3,4-dihydroxyphenylacetic acid (DOPAC) level in the median eminence (ME) and a corresponding decrease of serum prolactin (PRL) levels, which resulted from stimulation of tuberoinfundibular dopaminergic neurons. The CART peptide stimulated DOPAC levels in the striatum (ST), nucleus accumbens (NA), hypothalamic paraventricular nucleus (PVN), and periventricular (A14), but had no effect in the medial prefrontal cortex (MPFC) or suprachiasmatic nucleus (SCN). These effects of the CART peptide on stimulation of central DA systems and inhibition of PRL levels are specific because the inactive form of the CART peptide (0.1 and 1 microg) could not induce a similar response. Stimulatory effects of the CART peptide on different central DA systems displayed differential time-response profiles in the NA and ST, ME, and PVN and A14. These findings indicate that the CART peptide may selectively regulate certain central DA neuronal activities.